cdmo.directory
← Compare landing

Medpharm vs OMISAN S.p.A.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/medpharm/omisan

CategoryMedpharmOMISAN S.p.A.
Listed sitecdmocdmo
SummarySpecialized CDMO for topical, transdermal, and transepithelial drug products offering formulation development, analytical testing, process scale-up, and GMP manufacturing from early development through commercialization.Italian maker of sterile ophthalmic medical devices, including eye drops, sprays, eyewashes, and contact lens solutions. Offers private label and CDMO manufacturing for ophthalmic multinationals, with preservative-free dispensing technologies.
Services
  • Formulation Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Process Development
  • Technology Transfer
  • Topical & Semi-Solid Manufacturing
  • Ophthalmic Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
  • Quality Control Testing
  • Ophthalmic Manufacturing
Modalities
  • Small Molecule
Data not yet provided.
Indications
  • Respiratory
  • Dermatology
  • Ophthalmology
  • Ophthalmology
Locations
  • Headquarters, Guildford, England, United Kingdom
  • US Operations, Durham, North Carolina, United States
  • Headquarters, Guidonia Montecelio, RM, Italy
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.